# A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea

> **NCT02120924** · PHASE3 · COMPLETED · sponsor: **Actavis Inc.** · enrollment: 1009 (actual)

## Conditions studied

- Rosacea

## Interventions

- **DRUG:** Azelaic acid
- **DRUG:** Vehicle
- **DRUG:** Finacea

## Key facts

- **NCT ID:** NCT02120924
- **Lead sponsor:** Actavis Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 1009 (ACTUAL)
- **Last updated:** 2020-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02120924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02120924, "A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02120924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*